FDA Clearance Tracker · P040037
VIABAHN ENDOPROSTHESIS
Last checked: Nov 20, 2026Latest source record: Jun 14, 2005 (this decision)Source: openFDAMethods & limitations
Decided
Jun 14, 2005
Approved
Time to decision
291 days
Received Aug 27, 2004. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P040037
- Device name
- VIABAHN ENDOPROSTHESIS
- Applicant
- W. L. Gore & Associates, Inc.
- Applicant location
- Flagstaff, AZ
- Received
- Aug 27, 2004
- Decided
- Jun 14, 2005
- Decision
- Approved
- Supplements
- 165 in FDA's data for this PMA. See them on the FDA record
Device type
- Device type
- STENT, SUPERFICIAL FEMORAL ARTERY (NIP)
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR THE GORE VIABAHN ENDOPROSTHESIS. THE DEVICE IS INDICATED FOR IMPROVING BLOOD FLOW IN PATIENTS WITH SYMPTOMATIC PERIPHERAL ARTERIAL DISEASE IN SUPERFICIAL FEMORAL ARTERY LESIONS WITH REFERENCE VESSEL DIAMETERS RANGING FROM 4.8 TO 7.5 MM.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code NIP. The earliest in FDA's data is P000033, decided Apr 3, 2002.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for W. L. Gore & Associates, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- GORE® VIABAHN® VBX Balloon Expandable EndoprosthesisPMA supplement
P160021-S051 · Decided Oct 8, 2026 · 244 days after receipt · Panel Track
Device type: Iliac covered stent, arterial (PRL) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.